In this study, the CCl4-induced mouse model was used to study the intervention effect of CBD on liver fibrosis and to explore whether its potential mechanism is related to the inhibition of NF-κB and activation of the PPAR-α signaling pathway and anti-inflammatory and antioxidant stress damage. The gene discussed is NFKB1; the disease is Hepatic fibrosis.